These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3179887)

  • 1. The ethics of physician-pharmaceutical company relationships.
    Thompson WG
    CMAJ; 1988 Nov; 139(9):835-6. PubMed ID: 3179887
    [No Abstract]   [Full Text] [Related]  

  • 2. Conflict of interest in the physician interface with the biomedical industry.
    Minnigan H; Chisholm CD
    Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doctors and drug companies: the beauty and the beast?
    Guömundsson S
    Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
    [No Abstract]   [Full Text] [Related]  

  • 4. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
    Quan SF
    J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
    [No Abstract]   [Full Text] [Related]  

  • 5. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In defense of industry-physician relationships.
    Nakayama DK
    Am Surg; 2010 Sep; 76(9):987-94. PubMed ID: 20836349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snake oil and Caesar salad: the ethics of physician and pharmaceutical relationships.
    Woollard RF
    CMAJ; 1991 Oct; 145(8):931-3. PubMed ID: 1913426
    [No Abstract]   [Full Text] [Related]  

  • 8. Doctors, Drug Companies and Gifts: some local views.
    R I Med; 1992 Mar; 75(3):157-60. PubMed ID: 1554913
    [No Abstract]   [Full Text] [Related]  

  • 9. Beyond a pejorative understanding of conflict of interest.
    Williams-Jones B
    Am J Bioeth; 2011 Jan; 11(1):1-2. PubMed ID: 21240793
    [No Abstract]   [Full Text] [Related]  

  • 10. Physician-industry interactions: there is no such thing as a free lunch.
    Tsai HJ
    Taiwan J Obstet Gynecol; 2008 Jun; 47(2):252-5. PubMed ID: 18603524
    [No Abstract]   [Full Text] [Related]  

  • 11. Physicians and pharma--an unholy alliance?
    Borders JM
    J Ky Med Assoc; 2007 Apr; 105(4):177-8. PubMed ID: 17494281
    [No Abstract]   [Full Text] [Related]  

  • 12. Conflicts of interest.
    Ripps RA
    Conn Med; 2009 Jan; 73(1):37-8. PubMed ID: 19248573
    [No Abstract]   [Full Text] [Related]  

  • 13. [The physician and the conflict of interest].
    Lama A
    Rev Med Chil; 2003 Dec; 131(12):1463-8. PubMed ID: 15022411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulatory morass: physicians' dealings with pharmaceutical manufacturers.
    Blehart B
    J Med Pract Manage; 2003; 19(3):164-5. PubMed ID: 14730825
    [No Abstract]   [Full Text] [Related]  

  • 15. Physicians and drug representatives: exploring the dynamics of the relationship.
    Chimonas S; Brennan TA; Rothman DJ
    J Gen Intern Med; 2007 Feb; 22(2):184-90. PubMed ID: 17356984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cheers for the CMA's new guidelines on drug company-MD relations The CMA's MD-drug industry guidelines offer advice, nothing more.
    Rapp MS; Woollard R
    CMAJ; 1991 Dec; 145(11):1497-9. PubMed ID: 11649303
    [No Abstract]   [Full Text] [Related]  

  • 17. Giving and receiving of gifts between pharmaceutical and medical specialists in Australia.
    Wilson A
    Intern Med J; 2006 Dec; 36(12):795-6; author reply 796-7. PubMed ID: 17096745
    [No Abstract]   [Full Text] [Related]  

  • 18. Need for better interactions between physicians and pharmaceutical sales representatives.
    Ferguson RP
    Ann Pharmacother; 2002 Dec; 36(12):1966-8. PubMed ID: 12494952
    [No Abstract]   [Full Text] [Related]  

  • 19. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
    Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
    Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debunking myths in physician-industry conflicts of interest.
    Flach AJ
    Am J Ophthalmol; 2009 Mar; 147(3):562-3; author reply 563-4. PubMed ID: 19217965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.